Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Shane Cloney-Clark"'
Autor:
Prasad S. Kulkarni, Bhagwat Gunale, Sunil Kohli, Sanjay Lalwani, Srikanth Tripathy, Sonali Kar, Sidram Raut, Praveen Kulkarni, Aditi Apte, Ashish Bavdekar, Hira Lal Bhalla, Joyce S. Plested, Shane Cloney-Clark, MingZhu Zhu, Raj Kalkeri, Melinda Pryor, Stephanie Hamilton, Madhuri Thakar, Ranga S. Sannidhi, Punjita Baranwal, Chetanraj Bhamare, Abhijeet Dharmadhikari, Manish Gupta, Cyrus S. Poonawalla, Umesh Shaligram, Dhananjay Kapse, COVOVAX-Booster Study Group
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Due to waning immunity following primary immunization with COVID-19 vaccines, booster doses may be required. The present study assessed a heterologous booster of SII-NVX-CoV2373 (spike protein vaccine) in adults primed with viral vector and
Externí odkaz:
https://doaj.org/article/9a552b8a78384202b575842720c27791
Autor:
Zhaohui Cai, Raj Kalkeri, Mi Wang, Benjamin Haner, Dominic Dent, Bahar Osman, Paul Skonieczny, Jeremy Ross, Sheau-Line Feng, Rongman Cai, Mingzhu Zhu, Shane Cloney-Clark, Joyce S. Plested
Publikováno v:
Microorganisms, Vol 12, Iss 6, p 1201 (2024)
The evaluation of coronavirus disease 2019 (COVID-19) vaccine immunogenicity remains essential as the severe acute respiratory syncytial virus 2 (SARS-CoV-2) pandemic continues to evolve and as additional variants emerge. Neutralizing antibodies are
Externí odkaz:
https://doaj.org/article/5ca8ebd8330b4699901488187db063f4
Autor:
Zhaohui Cai, Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Benjamin Haner, Mi Wang, Bahar Osman, Dominic Dent, Sheau-Line Feng, Zach Longacre, Greg Glenn, Joyce S. Plested
Publikováno v:
Microorganisms, Vol 12, Iss 3, p 501 (2024)
Neutralizing antibody responses from COVID-19 vaccines are pivotal in conferring protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Effective COVID-19 vaccines and assays measuring neutralizing antibodies against emergin
Externí odkaz:
https://doaj.org/article/5858950851b847d3a887997ce88e0ecc
Autor:
Mingzhu Zhu, Shane Cloney-Clark, Sheau-line Feng, Anand Parekh, Drew Gorinson, David Silva, Paul Skonieczny, Adjele Wilson, Raj Kalkeri, Wayne Woo, Miranda R. Cai, Louis Fries, Greg Glenn, Joyce S. Plested
Publikováno v:
Microorganisms, Vol 11, Iss 7, p 1789 (2023)
As the COVID-19 pandemic continues, variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge. Immunogenicity evaluation of vaccines and identification of correlates of protection for vaccine effectiveness is critica
Externí odkaz:
https://doaj.org/article/7031ad406929446f93365e8f5df4cb5a
Autor:
Carolyn Rydyznski Moderbacher, Christina Kim, Jose Mateus, Joyce Plested, Mingzhu Zhu, Shane Cloney-Clark, Daniela Weiskopf, Alessandro Sette, Louis Fries, Gregory Glenn, Shane Crotty
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 19 (2022)
NVX-CoV2373 is an adjuvanted recombinant full-length SARS-CoV-2 spike trimer protein vaccine demonstrated to be protective against COVID-19 in efficacy trials. Here we demonstrate that vaccinated individuals made CD4+ T cell responses after 1 and 2 d
Externí odkaz:
https://doaj.org/article/d1bcb00519ff408b99a843d3d67b9a38
Autor:
Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Edmond Massuda, Urvashi Patel, Andrew Klindworth, Michael J. Massare, Rongman Cai, Louis Fries, Greg Glenn, Raj Kalkeri
Publikováno v:
Microorganisms, Vol 11, Iss 2, p 368 (2023)
Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show immune evasion of vaccine-derived immunity, highlighting the need for better clinical immunogenicity biomarkers. To address this need, an enzyme-linked immunosorbe
Externí odkaz:
https://doaj.org/article/eccebede663c4ad0a28cb35070d10ef6
Autor:
Katia Alves, Joyce S. Plested, Shirley Galbiati, Gordon Chau, Shane Cloney-Clark, Mingzhu Zhu, Raj Kalkeri, Nita Patel, Kathy Smith, Alex Marcheschi, Susan Pfeiffer, Heather McFall, Gale Smith, Gregory M. Glenn, Filip Dubovsky, Raburn M. Mallory
Publikováno v:
New England Journal of Medicine. 388:857-859
Autor:
Plested, Mingzhu Zhu, Shane Cloney-Clark, Sheau-line Feng, Anand Parekh, Drew Gorinson, David Silva, Paul Skonieczny, Adjele Wilson, Raj Kalkeri, Wayne Woo, Miranda R. Cai, Louis Fries, Greg Glenn, Joyce S.
Publikováno v:
Microorganisms; Volume 11; Issue 7; Pages: 1789
As the COVID-19 pandemic continues, variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge. Immunogenicity evaluation of vaccines and identification of correlates of protection for vaccine effectiveness is critica
Autor:
Germán Áñez, Karen L. Kotloff, Cynthia L. Gay, Joy Nelson, Haoua Dunbar, Shane Cloney-Clark, Alice McGarry, Wayne Woo, Iksung Cho, Joyce S. Plested, Gregory M. Glenn, Lisa M. Dunkle
BackgroundNVX-CoV2373, an adjuvanted, recombinant SARS-CoV-2 spike (rS) protein vaccine, consistently demonstrated protective efficacy against COVID-19 in clinical trials and has received regulatory authorizations or approvals worldwide.MethodsPREVEN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0a5eec2fa48ef2d3983c5b6516bea77
https://doi.org/10.1101/2023.05.08.23289670
https://doi.org/10.1101/2023.05.08.23289670
Autor:
Fritz Raiser, Matthew Davis, Jeffrey Adelglass, Miranda R. Cai, Gordon Chau, Shane Cloney-Clark, Mark Eickhoff, Raj Kalkeri, Irene McKnight, Joyce Plested, Mingzhu Zhu, Lisa Dunkle
BackgroundTo combat the SARS-CoV-2 pandemic, multiple vaccines using different manufacturing platforms have been developed, including NVX-CoV2373 (an adjuvanted recombinant protein vaccine). As SARS-CoV-2 variants have emerged, some of which evade va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64e3bd609836d2a17a83aefdd3b41b6a
https://doi.org/10.1101/2023.03.16.23287030
https://doi.org/10.1101/2023.03.16.23287030